Related by context. All words. (Click for frequent words.) 73 alanine aminotransferase ALT 72 microalbuminuria 72 alanine aminotransferase 72 overt nephropathy 72 serum phosphate 72 T2DM 71 glycated hemoglobin levels 71 aspartate aminotransferase AST 71 CTEPH 70 colorectal adenoma 70 serum urate 70 transaminase elevations 70 thyrotropin 70 atherogenic dyslipidemia 70 SGPT 69 aminotransferases 69 systolic dysfunction 69 aspartate aminotransferase 69 hypophosphatemia 69 systolic hypertension 69 elevated ALT 69 aminotransferase levels 69 lymphocytosis 69 hepatorenal syndrome 69 MetS 69 glycated hemoglobin 69 hypercalcemia 69 elevated serum creatinine 69 transaminase levels 69 autonomic dysfunction 69 diabetes mellitus DM 69 hyperglycaemia 69 PSA nadir 69 overt hypothyroidism 68 transaminases 68 serum urate levels 68 haematologic 68 preserved ejection fraction 68 AST ALT 68 elevated triglyceride levels 68 PAOD 68 hepatic enzymes 68 HBeAg negative 68 μmol L 68 onset diabetes mellitus 68 gastric adenocarcinoma 68 primary aldosteronism 68 colorectal carcinoma 68 nonalcoholic steatohepatitis 68 albuminuria 68 paroxysmal AF 68 albumin excretion 68 serum creatinine levels 68 neovascular 68 proliferative diabetic retinopathy 68 HbA 1c levels 68 subclinical hypothyroidism 68 serum HBV DNA 68 elevated IOP 68 hepatic cirrhosis 68 ADPKD 68 EDSS score 68 serous ovarian cancer 68 nonalcoholic steatohepatitis NASH 67 CIMZIA ™ 67 Hb A1C 67 corticosteroid dose 67 macrovascular complications 67 ALT flares 67 serum ALT 67 hyperparathyroidism 67 serum testosterone 67 serum IGF 67 intact parathyroid hormone 67 serum aminotransferase levels 67 hepatocellular carcinomas 67 liver metastasis 67 HbA 1c 67 antibody titer 67 hemoglobin A1c levels 67 leukocyte count 67 isolated systolic hypertension 67 arterial thromboembolic events 67 albumin excretion rate 67 β blockers 67 pheochromocytoma 67 hyperkalemia 67 hypertensives 67 ovarian carcinoma 67 LV dysfunction 67 mL/min/#.# m 2 67 nondiabetic patients 67 SCr 67 proliferative retinopathy 67 urothelial carcinoma 66 anemia hemoglobin 66 serum potassium 66 sinus bradycardia 66 CC genotype 66 prostate cancer CaP 66 apolipoprotein B 66 polyp recurrence 66 serum phosphate levels 66 NATRECOR ® 66 hematologic toxicity 66 relapsed MM 66 atrophic gastritis 66 MADRS score 66 INCB# [003] 66 Hypotension 66 epithelial tumors 66 left ventricular dysfunction 66 arterial hypertension 66 NMIBC 66 CrCl 66 NYHA functional class 66 thyrotropin levels 66 elevated LDH 66 glycosylated hemoglobin HbA1c 66 grade cervical intraepithelial 66 QTc prolongation 66 cinacalcet 66 thyroglobulin 66 glomerular filtration rate 66 thrombocytopenic 66 morphometric vertebral fractures 66 dopaminergic therapy 66 paricalcitol 66 serum uric acid 66 glomerular filtration 66 colorectal liver metastases 66 left ventricular systolic 66 gastric carcinoma 66 transferrin saturation 66 â ‰ ¥ 66 pericardial effusion 66 certolizumab 66 elevated triglycerides 66 airway hyperresponsiveness 66 IDDM 66 HIV HCV coinfected 66 achieved ACR# 66 hyperplastic 66 rFVIIa 66 renal dysfunction 66 prolonged QT interval 66 specific antigen PSA 66 oral antidiabetic medication 66 hypercalciuria 66 FDG uptake 66 neurological manifestations 66 cytopenias 66 leukemia AML 66 SHPT 66 x ULN 66 lactate dehydrogenase 66 Papillary 66 basal cell nevus syndrome 66 diabetes mellitus T2DM 66 pegaptanib 66 serum homocysteine 65 serum triglycerides 65 serum calcium levels 65 liver transaminases 65 HbF 65 cardiac dysfunction 65 Hashimoto thyroiditis 65 thyrotoxicosis 65 left ventricular hypertrophy 65 ximelagatran 65 mEq L 65 HOMA IR 65 advanced adenoma 65 myelodysplastic syndrome MDS 65 pT2 65 estimated GFR 65 HNSCC 65 renal cell carcinomas 65 histologic subtype 65 chronic hepatitis cirrhosis 65 Diabetic nephropathy 65 thromboembolic complications 65 isoprostane 65 prostate carcinoma 65 lipid abnormalities 65 timepoints 65 hypocalcemia 65 diastolic heart 65 Prehypertension 65 protein excretion 65 anterior uveitis 65 hepatic fibrosis 65 serum cortisol 65 BENICAR HCT 65 antihypertensive therapy 65 CVD mortality 65 carotid stenosis 65 severe exacerbations 65 Alanine 65 definite stent thrombosis 65 isoenzyme 65 pmol L 65 neoplasm 65 renal insufficiency 65 hyperacute 65 liver histology 65 cTnT 65 tolvaptan 65 fasting glucose levels 65 juvenile idiopathic arthritis JIA 65 urine albumin 65 dysglycemia 65 nonfasting triglyceride levels 65 dose cohort 65 APTIVUS r 65 CR nPR 65 lowest tertile 65 cryptogenic 65 ascites 65 postoperative AF 65 systemic corticosteroid 65 recurrent venous thromboembolism 65 progressive dyspnea 65 baseline serum creatinine 65 microvascular disease 65 DAS# CRP 65 Microalbuminuria 65 choroidal neovascularization 65 gallstone disease 65 IGFBP 65 OGTT 65 chemoradiation therapy 65 HER2 expression 65 intracranial hemorrhage ICH 65 lipohypertrophy 65 moderate renal impairment 65 neutropaenia 65 hypercholesterolaemia 65 ischemic lesions 65 elevated fasting glucose 65 HGPIN 65 onset atrial fibrillation 65 severe neutropenia 65 NNT = 65 PsA 65 coronary stenosis 65 triiodothyronine 65 lymphopenia 65 N telopeptide 65 octreotide LAR 65 serum parathyroid hormone 65 varices 65 microangiopathy 65 #.#mg/dL 65 geographic atrophy 65 lactate dehydrogenase LDH 65 corticosteroid therapy 65 hypokalemia 65 levodopa therapy 65 μg L 65 CP CPPS 65 MGUS 65 recurrent glioblastoma multiforme 65 Heavy menstrual bleeding 65 nodal metastasis 65 autoantibody positive 65 hemoglobin A1c HbA1c 65 HER2 overexpression 65 Natalizumab 65 dyslipidaemia 65 mRCC 65 leiomyomas 65 elevated creatinine 65 artery stenosis 65 adjunctive placebo 65 TEAEs 65 POAG 65 baseline LDH 65 hyperinsulinemia 64 advanced adenomas 64 ANCA associated 64 recurrent acute pancreatitis 64 microvascular complications 64 intravesical therapy 64 TNFalpha 64 dysfunction LVSD 64 neutrophil counts 64 pT3 64 proteinuria 64 endometrial hyperplasia 64 IL 1ß 64 glucocorticoid therapy 64 extrapyramidal symptoms 64 subependymal giant cell 64 intravenous bisphosphonates 64 Decitabine 64 EXJADE 64 tumor histology 64 leucopenia 64 hypoxemia 64 invasive candidiasis 64 umol L 64 CIN3 64 Erythropoietic therapies may 64 non squamous NSCLC 64 CK MB 64 sUA 64 posttransplant 64 mild renal insufficiency 64 chronic thromboembolic pulmonary 64 urolithiasis 64 adverse cytogenetics 64 resectable 64 systemic lupus erythematosus SLE 64 depressive symptomatology 64 metaplasia 64 IPAH 64 serum triglyceride levels 64 ALT elevations 64 histological subtype 64 CIN2 + 64 alteplase 64 hypercalcaemia 64 inotropic 64 hyperbilirubinemia 64 myocardial ischemia 64 urinary N telopeptide 64 STRIDE PD 64 T1DM 64 uM 64 beta blocker therapy 64 ertapenem 64 abdominal adiposity 64 QTc 64 hemoglobin concentration 64 mucinous 64 improves glycemic 64 pCR 64 severe renal impairment 64 bacteriuria 64 salmeterol fluticasone 64 ara C 64 serum lipid levels 64 CIMZIA TM 64 primary hypercholesterolemia 64 osteosarcomas 64 pentoxifylline 64 primary hyperparathyroidism 64 biochemical recurrence 64 ATACAND 64 epithelial ovarian cancer 64 serum ferritin 64 intravitreal injections 64 diabetic kidney 64 fasting triglycerides 64 antiarrhythmic drug 64 hsCRP levels 64 genotypic resistance 64 hypoglycemic episodes 64 creatine kinase MB 64 euthyroid 64 intima media thickness 64 murine model 64 latent celiac disease 64 Index CDAI 64 Serum creatinine 64 thromboembolism 64 IFN beta 64 Leydig cell 64 Retreatment 64 preoperative PSA 64 EDSS scores 64 hematopoietic cancers 64 PSADT 64 secondary hyperparathyroidism 64 diabetes mellitus 64 cardiac troponin T 64 HoFH 64 K ras mutations 64 neurocognitive deficits 64 HbA1C levels 64 pulmonary exacerbations 64 Non Alcoholic Fatty 64 TNF antagonist 64 affective psychosis 64 hyperphenylalaninemia HPA due 64 creatinine ratio 64 inhibitor RG# 64 myeloproliferative neoplasms 64 atrioventricular block 64 Endothelial dysfunction 64 Hematologic 64 lactic acidosis 64 Adjuvant chemotherapy 64 cervical intraepithelial neoplasia 64 riociguat 64 p = #.# [003] 64 Neovascular AMD 64 endometrial thickness 64 generalized edema 64 angiotensin converting enzyme inhibitors 64 insulin resistance syndrome 64 salmeterol fluticasone propionate 64 hormone receptor negative 64 VAPRISOL 64 adenomatous 64 aminotransferase ALT 64 nonvertebral fractures 64 thrombocytopenic patients 64 Ribavirin causes 64 pulmonary metastases 64 ALT elevation 64 PCa 64 polyarticular 64 hematologic parameters 64 nephrolithiasis 64 tumor lysis syndrome 64 mesalamine granules 64 hypercoagulable 64 nonfatal MI 64 elevated LDL cholesterol 64 leukocytosis 64 adenomatous polyps 64 pg mL 64 hepatic steatosis 64 serum sodium 64 osteopenic 64 creatinine clearance 64 CYT# potent vascular disrupting 64 eculizumab therapy 64 HBeAg negative patients 64 Proteinuria 64 plasma triglycerides 64 GnRH agonist 64 ALB # 64 ruboxistaurin 64 echocardiographic parameters 63 intestinal polyps 63 systemic lupus erythematosus 63 Hp2 2 63 mcg BID 63 urinary albumin 63 myeloproliferative diseases 63 creatinine levels 63 diabetic nephropathy 63 LVSD 63 metastatic malignant 63 skeletal metastases 63 GSTM1 63 premalignant lesions 63 hyperalgesia 63 virologic response 63 PASI scores 63 serum TSH 63 mmol l 63 microscopic hematuria 63 posttreatment 63 left ventricular diastolic 63 choroidal neovascularization CNV 63 atorvastatin #mg 63 demyelinating 63 confidence interval #.#-#.# 63 prostate cancer PCa 63 SGOT 63 hematological parameters 63 INVEGA ® 63 % Confidence Interval 63 hemorrhagic complications 63 essential thrombocythemia 63 esophageal squamous cell carcinoma 63 alkaline phosphatase 63 amenorrhoea 63 reflux esophagitis 63 anagrelide 63 Venous thromboembolism 63 peptide BNP 63 troponin T 63 laboratory abnormalities 63 aminotransferase 63 leukopenia 63 hypoglycemic events 63 neutropenia thrombocytopenia 63 macrovascular disease 63 homozygous familial hypercholesterolemia 63 methotrexate therapy 63 basal cell carcinoma BCC 63 nmol 63 C1 INH deficiency 63 pulmonary dysfunction 63 symptomatic VTE 63 lichen planus 63 KRAS mutations occur 63 HbA1C 63 renal cysts 63 ≥ 63 carcinoids 63 lymphocyte counts 63 HBeAg 63 CRVO 63 abnormal glucose metabolism 63 serum GGT 63 Critical Limb Ischemia CLI 63 sulfasalazine 63 CTAP# Capsules 63 idiopathic PAH 63 premalignant 63 DMARD 63 atypical ductal hyperplasia 63 subclinical inflammation 63 CLA supplementation 63 urinary albumin excretion 63 schizophrenia CIAS 63 hypovitaminosis D 63 insulin detemir 63 timepoint 63 seropositivity 63 rFSH 63 metastatic gastric 63 L PPDS 63 idarubicin 63 Primary endpoints 63 lobular carcinoma 63 AA Amyloidosis 63 CMV infection 63 NYHA Class II 63 ß blockers 63 erythrocyte sedimentation rate 63 Toxicities 63 elevated transaminases 63 invasive ductal 63 PRADAXA #mg 63 hepatic enzyme 63 GI motility 63 atherosclerotic vascular disease 63 intestinal metaplasia 63 recurrent VTE 63 triglyceride concentrations 63 IFN α 63 myelofibrosis polycythemia vera 63 airflow obstruction 63 mIU L 63 serum calcium 63 serum phosphorous 63 rs# [004] 63 impaired fasting glucose 63 NPH insulin 63 CI -#.# 63 concomitant medications 63 cirrhotic 63 pyridostigmine 63 flutamide 63 ADAS Cog 63 coagulopathy 63 serum PSA 63 calculi 63 retransplantation 63 hyperlipidaemia 63 glycated hemoglobin HbA1c 63 hip BMD 63 interleukin IL -6 63 complete cytogenetic response 63 cTnI 63 insulin degludec 63 nephropathy 63 teriparatide 63 stage IIIB 63 ischemic cardiomyopathy 63 Non Alcoholic Steatohepatitis 63 polycythemia vera PV 63 T1a 63 liposomal amphotericin B 63 IV NSCLC 63 serum prostate 63 lenalidomide dexamethasone 63 Insulin resistance 63 Haptoglobin 63 chorioamnionitis 63 dopamine partial agonist 63 neurologic complications 63 mucosal healing 63 NATRECOR R 63 serum phosphorus 63 thrombocytosis 63 antiangiogenic therapy 63 MCyR 63 GH deficiency 63 EDARBI 63 complement inhibitor eculizumab 63 chlorambucil 63 nitrotyrosine 63 pulmonary hypertension PH 63 endotoxemia 63 somatostatin analog 63 glucose intolerance 63 metabolic acidosis 63 symptomatic intracranial 63 fasting plasma glucose 63 MULTAQ 63 LV ejection fraction 63 anthracycline chemotherapy 63 Flu Cy 63 ibandronate 63 postoperative complication 63 p = .# [002] 63 arthropathy 63 fibrin deposition 63 hydroxyvitamin D levels 63 tertile 63 Vaprisol 63 poor metabolizers 63 F FDG PET 63 neutrophil count 63 rheumatoid factor 63 bladder carcinoma 63 mg BID dose 63 calcineurin inhibitor 63 interstitial pneumonia 63 immune thrombocytopenic purpura 63 HeFH 63 hypomagnesemia 63 aortic regurgitation 63 Eur J Endocrinol 63 serum leptin 63 cardioembolic stroke 63 TMP SMX 63 ACTEMRA TM 63 CK # plasma concentrations 63 anastomotic leak 63 #mg/dL [001] 63 highest tertile 63 papillary renal cell carcinoma 63 myeloperoxidase 63 #mg BID [001] 63 titrated glipizide 63 clomipramine 63 virologic breakthrough 63 carcinoid tumors 63 hypoperfusion 63 iPTH 63 atheroma volume 63 plasminogen activator inhibitor 63 adenocarcinomas 63 fluticasone salmeterol 63 abnormal lipid 63 #.#mmol L [002] 63 PNH patients 63 bronchial hyperresponsiveness 63 renal allograft 63 vWD 63 HBeAg positive 63 macrovascular 63 MACCE 63 interstitial fibrosis 63 Immunohistochemical analysis 63 treat benign prostatic 63 gastrointestinal perforation 63 HBeAg seroconversion 63 Postoperative complications 63 chronic GVHD 63 vertebral fracture 63 postintervention 63 progressive neurodegenerative disorder 63 T2 lesions 63 Infusion Reactions Severe 63 paragangliomas 63 plasminogen activators 63 fasting hyperglycemia 63 efalizumab 63 intracerebral haemorrhage 63 HBeAg positive patients 63 virological response 63 antigen PSA levels 63 detemir 63 conjunctival hyperemia 63 nonfasting triglycerides 63 infarcts 63 thymoma 63 histologically proven 63 estimated glomerular filtration 63 Hurthle cell 63 juvenile idiopathic arthritis 63 mm Hg systolic 63 milrinone 63 acute gout flares 63 tHcy 63 metabolic disturbances 63 euthymic patients 63 serum PTH 63 Chronic HCV 63 CsA 63 FOLPI regimen 63 unknown etiology 63 taxane resistant 63 platelet reactivity 63 Subgroup analysis 63 de novo AML 63 GSTP1 63 valvular disease 63 chronic renal insufficiency 63 loop diuretics 63 multivariable analysis 63 HSCT 63 thromboembolic 62 SCIg 62 baseline FEV 62 autoantibody levels 62 neurologic symptoms 62 baseline HbA1c 62 caspofungin 62 thromboembolic disease 62 gastric cardia 62 Impaired glucose tolerance 62 biochemical relapse 62 Fasting glucose 62 serum CRP 62 normotensive 62 #.#g/day 62 Renal dysfunction 62 hyperhomocysteinemia 62 hemodilution 62 orchitis 62 Ischemic 62 myocardial ischaemia 62 E selectin 62 postprandial glycemia 62 alemtuzumab treated 62 β blocker 62 epithelioid 62 adenoma 62 hypertension diabetes mellitus 62 TP# mutations 62 pancreatic insufficiency 62 receptor tyrosine kinase inhibitor 62 serum sodium levels 62 mmHg diastolic 62 Leukemias 62 bezafibrate 62 μg liter 62 haemolysis 62 completely resected 62 eGFR 62 cytomegalovirus infection 62 eosinophilia 62 parkinsonism 62 non hematological toxicities 62 gouty arthritis 62 Multivariate analysis showed 62 immunocompetent 62 pyelonephritis 62 microglial activation 62 olmesartan 62 LHRH agonist 62 Chronic pancreatitis 62 recurrent genital herpes 62 distant metastases 62 Fasting blood glucose 62 breast carcinoma 62 normal ULN 62 hydronephrosis 62 follicular lymphoma FL 62 trastuzumab Herceptin ® 62 nondiabetics 62 glycosylated hemoglobin 62 hyperglycemia 62 adiponectin concentrations 62 QTcF 62 granulomatous 62 unresectable tumors 62 inotropic agents 62 neurologic deficits 62 gadolinium enhanced 62 Nilotinib 62 Crohn Disease Activity 62 GISTs 62 #mmHg [001] 62 periprocedural 62 radioiodine therapy 62 glycemia 62 neoplasias 62 ejection fractions 62 elevated CRP 62 salmeterol HFA MDI 62 hours postdose 62 tipranavir ritonavir 62 carotid plaques 62 nutlin 3a 62 tipranavir r 62 serum concentrations 62 piperacillin tazobactam 62 hepatic lesions 62 cystatin C 62 DFMO 62 oral FTY# 62 bioavailable testosterone 62 hypercholesterolemia 62 renal impairment 62 torsade de pointes 62 myocardial infarctions 62 follicular lymphomas 62 severe renal insufficiency 62 Elitek 62 subsyndromal 62 receptor blocker 62 metformin sulfonylurea 62 OADs 62 eplerenone 62 Myelodysplastic Syndrome MDS 62 nonsmall cell lung cancer 62 chronic periodontitis 62 vWF 62 Sezary syndrome 62 hyperammonemia 62 colorectal neoplasms 62 nonischemic 62 urate lowering therapy 62 thyroid carcinoma 62 urinary oxalate 62 nonmetastatic 62 urothelial cancer 62 8mg/kg 62 hemodialysis patients 62 recurrent UTI 62 OSAHS 62 4mg/kg 62 invasive aspergillosis 62 HbA1c levels 62 BYSTOLIC 62 B7 H3 62 Ramipril 62 amisulpride 62 carcinoid 62 thromboembolic events 62 acromegalic patients 62 cholestasis 62 euvolemic 62 postoperative morbidity 62 glomerular 62 FluCAM arm 62 Primary IGFD 62 evaluable subjects 62 Doxil ® 62 oral prednisolone 62 SJIA 62 localized renal 62 ‰ ¥ 62 hypercholesterolemic patients 62 Fas ligand 62 Lp PLA 2 62 leukocyte counts 62 aminotransferase elevations greater 62 IDH1 mutation 62 hepatitis C genotype 62 HMGA1 62 DAS# [002] 62 differentiated thyroid 62 histologically confirmed 62 Squamous 62 colorectal carcinomas 62 mycophenolate mofetil 62 IgA deficiency 62 chronic myeloid 62 gene polymorphism 62 pyrazinamide 62 TNF blocker therapy 62 myocardial fibrosis 62 perioperative morbidity 62 myelofibrosis MF 62 NIHSS 62 diastolic hypertension 62 atherosclerotic lesion 62 detrusor 62 tumor xenograft models 62 urine cytology 62 FDG PET imaging 62 esophageal varices 62 antidiabetic drugs 62 biliary tract cancer 62 AGILECT R 62 cell lymphoma CTCL 62 NIH CPSI 62 cardiac troponin 62 neovascularization 62 interleukin IL -# 62 myeloproliferative disorder 62 partial remissions 62 decompensated heart failure 62 CIMZIA TM certolizumab pegol 62 fasting triglyceride levels 62 elevated lipase 62 chemoradiotherapy 62 eNO 62 nephrotoxicity 62 airflow limitation 62 intrahepatic 62 Diabetic neuropathy 62 adenoma recurrence 62 rhGH 62 PaO 2 62 unresectable HCC 62 cystic lesions 62 ACE Inhibitor 62 Thiazolidinediones 62 stratifying patients 62 univariate analysis 62 soluble CD# ligand 62 univariate analyzes 62 VaD 62 lipid lowering agents 62 serum biomarker 62 ASCUS 62 subclinical hyperthyroidism 62 hepatic dysfunction 62 TREDAPTIVE 62 leukoencephalopathy 62 graft dysfunction 62 androgen ablation 62 lymphocytic 62 triacylglycerol 62 intravitreal triamcinolone 62 paroxysmal atrial fibrillation 62 hamartomas 62 hydroxyvitamin D concentrations 62 neovascular glaucoma 62 C Reactive Protein 62 mU liter 62 CHOP chemotherapy 62 advanced neoplasia 62 intravitreal bevacizumab 62 subclinical atherosclerosis 62 transaminase 62 optic neuropathy 62 MMSE score 62 activin 62 ULORIC 62 pericardial effusions 62 FOLPI 62 TNF Tumor Necrosis Factor 62 myopathy rhabdomyolysis 62 hepatocellular 62 hyperoxaluria 62 giant cell arteritis 62 congenital deficiency 62 acetabular dysplasia 62 pancreatic adenocarcinoma 62 dosing cohort 62 carotid IMT 62 neovascular AMD 62 hepatoma 62 LV hypertrophy 62 purpura ITP 62 Lantus ® 62 ABCB1 62 paresthesias 62 imatinib therapy 62 RYGB 62 basal bolus regimen 62 lipoprotein levels 62 hepatic metastases 62 #mg/dl 62 irbesartan 62 impaired glucose tolerance 62 macrovascular events 62 calculated creatinine clearance 62 cortisol secretion 62 mg kg dose 62 Aortic stenosis 62 nonproliferative 62 Hypertrophy 62 Montgomery Åsberg Depression 62 dysuria 62 triglyceride concentration 62 inflammatory biomarkers 62 Severe Primary IGFD 62 cranial irradiation 62 hepatic encephalopathy HE 62 hypocalcaemia 62 histologically 62 seropositive patients 62 unfavorable cytogenetics 62 oral Hycamtin 62 pamidronate 62 creatine kinase 62 HER2 positive cancers 62 PTHrP 62 inhaled corticosteroid therapy 62 receiving VICTRELIS 62 antiphospholipid syndrome 62 Legg Calvé Perthes disease 62 diarrhea predominant irritable 62 TNF α 62 BARACLUDE ® 62 hyperplasia 62 SIADH 62 mCi 62 cerebral vasospasm 62 sitosterol 62 lipid concentrations 62 PREZISTA r arm 62 COPD exacerbation